Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended May 2025 is 14.72% vs 16.16% in May 2024
Consolidate Net Profit
YoY Growth in quarter ended May 2025 is -25.66% vs 0.00% in May 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended May 2025 is 1.46% vs -12.82% in May 2024
Interest
YoY Growth in quarter ended May 2025 is 100.00% vs 1,800.00% in May 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended May 2025 has fallen from May 2024
Compare Quarterly Results Of Daito Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended May 2025 is 17.87%
YoY Growth in quarter ended May 2025 is 14.72% vs 16.16% in May 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended May 2025 is 180.08%
YoY Growth in quarter ended May 2025 is -25.66% vs 0.00% in May 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended May 2025 is 11.47%
YoY Growth in quarter ended May 2025 is 1.46% vs -12.82% in May 2024
Quarterly - Interest
QoQ Growth in quarter ended May 2025 is 11.76%
YoY Growth in quarter ended May 2025 is 100.00% vs 1,800.00% in May 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended May 2025 has improved from Nov 2024
YoY Growth in quarter ended May 2025 has fallen from May 2024






